HCW Biologics Inc.
HCWB
$4.99
-$0.27-5.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 90.75% | 73.49% | 67.72% | 70.29% | 9.63% |
| Total Depreciation and Amortization | -43.76% | -12.04% | 101.87% | 64.43% | 25.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -795.43% | -466.05% | -92.45% | -110.55% | -80.45% |
| Change in Net Operating Assets | -120.49% | -120.45% | -118.99% | -115.23% | 457.92% |
| Cash from Operations | 18.99% | 5.88% | 15.81% | 30.04% | 37.11% |
| Capital Expenditure | -- | -- | 97.07% | 96.62% | 97.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 97.07% | -102.72% | -103.32% |
| Total Debt Issued | -97.09% | -97.83% | -91.96% | -9.32% | 194.57% |
| Total Debt Repaid | -190.02% | -6.87% | -6.88% | -27.70% | -79.71% |
| Issuance of Common Stock | 102.72% | 24.31% | 347.18% | 267.97% | 56.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 63.04% | 12.63% | -- | -- | -- |
| Cash from Financing | 2.49% | -31.47% | 46.53% | 128.55% | 168.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.07% | -352.17% | 100.96% | 120.32% | 79.19% |